Kidney Cancer

If you or your loved one has been diagnosed with kidney cancer, Memorial Sloan-Kettering Cancer Center is ready to help. Our experienced team of doctors, nurses, and other healthcare professionals is dedicated to providing expert diagnostic services, the highest-quality treatment, and comprehensive support services for our patients.

In this section

Making an Appointment

Call 800-525-2225
Mon–Fri, 8:00 AM–6:00 PM, ET

Watch a video|For referring physicians

Pictured: Robert Motzer
Sidney Kimmel Center for Prostate and Urologic Cancers

Our state-of-the-art treatment center is focused entirely on genitourinary cancers — tumors of the prostate, kidney, bladder, or testicle.

Pictured: Robert Motzer
Pictured: Martee Hensley
Becoming a Patient: The First Steps

If you have recently been diagnosed with cancer or a related disease, we can help you understand your treatment options.

Pictured: Martee Hensley
Prediction Tools

Use our online nomogram to calculate the risk of cancer recurrence following surgery for renal cell carcinoma. Results can help physicians and patients make important treatment decisions.

Targeted Therapies for Advanced Kidney Cancer

Our physicians and scientists are pioneering the development of targeted therapies for kidney cancer. Our experts have participated in or led the development of five of the seven drugs approved by the US Food and Drug Administration for patients with advanced kidney cancer since 2005.

Pictured: Paul Russo
Surgery for Kidney Cancer

Kidney-sparing surgery, including minimally invasive laparoscopic and robotic techniques, is now an option for many people with kidney tumors.

Pictured: Jonathan Coleman
Quality-of-Life Issues in Kidney Cancer Treatment

Avoiding unnecessary side effects is an important part of kidney cancer treatment at Memorial Sloan-Kettering.

Targeted Therapies
Pictured: Paul Russo
Surgery
Pictured: Jonathan Coleman
Quality of Life
See More Kidney Cancer Videos | See All Videos »

On Our Blog

Comparison of Drugs for Advanced Kidney Cancer Suggests Side Effects Are More Manageable with Newer Option

Pramod Sogani Inaugurated As President of the American Urological Association

Many Affected by Kidney Cancer Are Not Informed about Kidney-Sparing Surgery Option

Physicians and Scientists at Memorial Sloan-Kettering Pioneer the Development of Kidney Cancer Treatments

Meet Urologic Cancer Surgeon Guido Dalbagni

Related Media Coverage

HealthDay: Kidney Cancer Drugs Equal in Prolonging Survival: Study

See all »